Article Versions Notes

Oubaddou Y, Oukabli M, Fenniche S, Elktaibi A, Elochi MR, Al Bouzidi A, Qmichou Z, Dakka N, Diorio C, Richter A, et al. BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach. Genes. 2023; 14(9):1680. https://doi.org/10.3390/genes14091680

Oubaddou, Yassire, Mohamed Oukabli, Salma Fenniche, Abderrahim Elktaibi, Mohamed Reda Elochi, Abderrahmane Al Bouzidi, Zineb Qmichou, Nadia Dakka, Caroline Diorio, Antje Richter, and et al. 2023. "BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach" Genes 14, no. 9: 1680. https://doi.org/10.3390/genes14091680

Oubaddou, Y., Oukabli, M., Fenniche, S., Elktaibi, A., Elochi, M. R., Al Bouzidi, A., Qmichou, Z., Dakka, N., Diorio, C., Richter, A., Bakri, Y., & Ameziane El Hassani, R. (2023). BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach. Genes, 14(9), 1680. https://doi.org/10.3390/genes14091680